USPTO serial 97351418
Serial No. 97351418
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 16, 2024
- Examiner
- GULIANO, ROBERT N
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 97351418?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
SUWON-SI, GYEONGGI-DO, KR
SUWON-SI, GYEONGGI-DO, KR
SUWON-SI, GYEONGGI-DO, KR
Gyeonggi-do,, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
DENNIS S. PRAHL
DENNIS S. PRAHL LADAS & PARRY LLP1040 AVENUE OF THE AMERICASNEW YORK, NY 10018UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals for the treatment of neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder; Pharmaceutical preparations for health care for the treatment of cancer; pharmaceutical products for the treatment of cancer; allergy medications; vaccines; pharmaceutical preparations for the treatment of damaged cells; drug delivery agents in the form of capsules, granules, liquids, transdermal patches, pellets, pills, powders, solutions, suspensions or tablets that facilitate the delivery of pharmaceutical preparations; adjuvants for medical purposes; medicated skin care preparations | ACTIVE | Apr 7, 2022 |
| 042 | Research and development of vaccines and medicines; development of pharmaceutical preparations and medicines; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical laboratories; Medical research; testing of pharmaceuticals; clinical research in the field of medicine for the treatment of neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder | ACTIVE | Apr 7, 2022 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by IMNEWRUN, INC.
- Other trademarks owned by IMNEWRUN, INC.
- Other trademarks owned by IMNEWRUN, INC.
- Other trademarks owned by imnewrun Biosciences, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 16, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 16, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 12, 2024 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Mar 9, 2024 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Feb 17, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Feb 17, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 25, 2024 | IUAF | USE AMENDMENT FILED | — |
| Jan 25, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 25, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 30, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 30, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 10, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 21, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 8, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 7, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 7, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 17, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 17, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 17, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 13, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 29, 2022 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| May 4, 2022 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| May 4, 2022 | ALIE | ASSIGNED TO LIE | — |
| Apr 28, 2022 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Apr 13, 2022 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Apr 12, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 11, 2022 | NWAP | NEW APPLICATION ENTERED | — |